EUVIMEDEUVIMED entdecken
Crossref

Impact of human leucocyte antigen class II polymorphism on anti‐red blood cell antibody development: Correlations and indications

Milanka Milosavić, Marko Lilić iD, Zorana Andrić

Vox Sanguinis · 2024

DOI: 10.1111/vox.13632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Milanka Milosavić und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Immunohematology, Institute for Transfusion Medicine of Republika Srpska, Banja Luka, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: HLA-DQ beta-Chains, Polymorphism, Genetic, HLA-DRB1 Chains, Isoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Government of Republika Srpska.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backround and Objectives Blood transfusion therapy is vital for many patient groups. They can cause many complications, and the development of anti‐red blood cell (RBC) antibodies is of significant importance. Molecules of class II human leucocyte antigens (HLA) are one of the several factors that influence antibody development in patients. Materials and Methods In this study, we investigated 108 patients who developed antibodies against different erythrocyte antigens and 115 patients on multiple transfusion therapies who did not develop anti‐RBC antibodies. The HLA loci HLA‐DRB1 and HLA‐DQB1 were typed using commercial molecular assays routinely used in HLA laboratories.

Results

An increased frequency of the HLA‐DRB1*04 allele group was observed in patients who developed antibodies. Additionally, HLA‐DRB1*09 was also significant for anti‐E development and in patients with multi‐specific alloimmunization. It was found that the HLA‐DRB1*07 allele group is associated with antibodies to antigents of the Rh and MNS systems but also lacks an association with anti‐K development. The HLA‐DRB1*11 and ‐DRB1*01 allele groups displayed a protective mechanism for anti‐E development, similar to that of HLA‐DQB1*02 for anti‐K.

Conclusion

There is an association between various HLA class II alleles and anti‐RBC development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-DQ beta-ChainsPolymorphism, GeneticHLA-DRB1 ChainsIsoantibodiesHumansMaleFemaleErythrocytesAdultMiddle AgedAlleles

Stichwörter der Autor:innen

antibodiesblood therapyhuman leucocyte antigensimmune responsered blood cell

Substanzen

HLA-DQ beta-ChainsHLA-DRB1 ChainsIsoantibodiesHLA-DQB1 antigen

Autor:innen und Institutionen

  • Laboratory for Molecular Immunohematology, Institute for Transfusion Medicine of Republika Srpska, Banja Luka, Bosnia and Herzegovina.
  • Department of Biology, University of Osijek, Osijek, Croatia.
  • Tissue Typing Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia.

ORCID-Profile: Marko Lilić

Förderung

  • Government of Republika Srpska

Zitieren

APA

Milosavić, M., Lilić, M., & Andrić, Z. (2024). Impact of human leucocyte antigen class II polymorphism on anti‐red blood cell antibody development: Correlations and indications. Vox Sanguinis. https://doi.org/10.1111/vox.13632

Vancouver

Milosavić M, Lilić M, Andrić Z. Impact of human leucocyte antigen class II polymorphism on anti‐red blood cell antibody development: Correlations and indications. Vox Sanguinis. 2024. doi:10.1111/vox.13632

BibTeX
@article{Milosavi2024,
  author = {Milosavić, Milanka and Lilić, Marko and Andrić, Zorana},
  title = {Impact of human leucocyte antigen class II polymorphism on anti‐red blood cell antibody development: Correlations and indications},
  journal = {Vox Sanguinis},
  year = {2024},
  doi = {10.1111/vox.13632}
}
Kostenlos starten →